CEO pay benchmark · $2B – $10B
Mid-cap Pharmaceutical Preparations CEO salary
The median CEO compensation at mid-cap companies in the pharmaceutical preparations industry is $13,342,739. That is 21% higher than the median across all pharmaceutical preparations companies in our benchmark.
Median CEO pay
$13.3M
Typical range
$9.7M–$14.7M
Companies
13
Average pay ratio
Not available
Vs. full industry
+21%
Size effect
How this group compares with the full industry
The same compensation measures are shown side by side, so the company-size difference is visible without mixing in another dataset.
| Measure | Mid-cap | All Pharmaceutical Preparations |
|---|---|---|
| Companies | 13 | 34 |
| Median CEO pay | $13,342,739 | $11,000,803 |
| Average CEO pay | $12,071,921 | $11,937,695 |
| Middle 50% range | $9.7M–$14.7M | $7.9M–$15.2M |
| Average pay ratio | Not available | 5:1 |
Company appendix
Highest CEO pay in this peer group
Up to ten of the highest-paid CEOs in this benchmark, ordered by total annual compensation. Open any company for its full pay breakdown.
| Company | CEO | Total compensation | Market cap |
|---|---|---|---|
| Nuvalent, Inc.NUVL | James R. Porter | $17.3M | $9.0B |
| Organon & Co.OGN | Kevin Ali | $15.8M | $3.5B |
| SUPERNUS PHARMACEUTICALS, INC.SUPN | Jack A. Khattar | $15.5M | $2.7B |
| RHYTHM PHARMACEUTICALS, INC.RYTM | David P. Meeker | $14.7M | $7.2B |
| Atrium Therapeutics, Inc.RNA | Sarah Boyce | $14.2M | $2.1B |
| Acadia Pharmaceuticals Inc.ACAD | Stephen R. Davis | $14.0M | $5.1B |
| Apellis Pharmaceuticals, Inc.APLS | Cedric Francois | $13.3M | $5.2B |
| Protagonist Therapeutics, IncPTGX | Dinesh V. Patel | $12.9M | $8.2B |
| Merus N.V.MRUS | Sven (Bill) Ante Lundberg | $9.7M | $6.8B |
| Arcus Biosciences, Inc.RCUS | Terry Rosen | $9.7M | $3.8B |
Nearby peer groups